Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma

We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mansour, Ahmad M., Arevalo, J. Fernando, Al Kahtani, Eman, Zegarra, Hernando, Abboud, Emad, Anand, Rajiv, Ahmadieh, Hamid, Sisk, Robert A., Mirza, Salman, Tuncer, Samuray, Navea Tejerina, Amparo, Mataix, Jorge, Ascaso, Francisco J., Pulido, Jose S., Guthoff, Rainer, Goebel, Winfried, Roh, Young Jung, Banker, Alay S., Gentile, Ronald C., Martinez, Isabel Alonso, Morris, Rodney, Panday, Neeraj, Min, Park Jung, Mercé, Emilie, Lai, Timothy Y. Y., Massoud, Vicky, Ghazi, Nicola G.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2014
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4132478/
https://ncbi.nlm.nih.gov/pubmed/25147732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/210458
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars